Foghorn Therapeutics (NASDAQ:FHTX) Given “Buy” Rating at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Foghorn Therapeutics (NASDAQ:FHTX – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $13.00 price target on the stock. FHTX has been the topic of a number of other reports. Jefferies Financial Group decreased their price objective on Foghorn […]
HC Wainwright reaffirmed their buy rating on shares of Foghorn Therapeutics (NASDAQ:FHTX – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $13.00 price target on the stock. FHTX has been the topic of a number of other reports. Jefferies Financial Group decreased their price objective on Foghorn […]
